🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The postdoc stage was the hardest for me. Even with the best mentors, the stress from the uncertainty and the self-doubt is very real. Hang in there postdocs. #postdocappreciationweek

"vaccination has averted 154 million deaths" On the 50th anniversary of WHO's Expanded Programme on Immunization, Naor Bar-Zeev & colleagues quantify the public health impact of vaccination: hubs.ly/Q02ymFn60

La impotència d'un veinat. Veïns del centre de Mataró denuncien l’ocupació “insostenible” d’un bloc de pisos elpuntavui.cat/societat/artic… via El Punt Avui 🎗️ Ajuntament de Mataró Policia Local de Mataró Mossos

🧬💪 En CURA CROHN, pacientes del Hospital Clínic Barcelona transforman su experiencia en acción. Organizamos eventos para financiar investigaciones innovadoras sobre la enfermedad de Crohn y la Colitis Ulcerosa. ¡Tu apoyo puede marcar la diferencia! 🌟🔬 #Investigación #IBD

If you have #IBD #Crohns #Colitis & looking for #PsychologicalSupport, I am running a 1hr event on 16th Sept, 6pm, about acceptance & commitment therapy for IBD I will also be sharing info about our new group mental health programme launching soon! Link➡️eventbrite.co.uk/e/how-can-acce…

What happens to intestinal cells when patients are treated with tofacitinib? Why do responses vary between patients? Check out a new preprint from our lab for some responses IBD lab IBD Leuven #IBD #scRNAseq biorxiv.org/content/10.110…

Please RT 🙏!📢My lab at Universitat de Barcelona is seeking a highly motivated postdoc to lead an exciting new public-private collaborative project (UB, CRG, CSIC, OrikineBio) aimed at testing a potentially game-changing therapy for IBD. If interested, please contact me at [email protected].

🎙️ Mecanismos patogénicos en enfermedades inmunomediadas: ¿vías orgánicas vs comunes? 👥Únete a los expertos para conocer los mecanismos patogénicos de la inflamación y el daño orgánico, centrados en órganos y sistemas Regístrate👇 aulaclinic.com/cursos/view.ph…

With the right people, right funding, and right opportunity, we at FIBROTARGET are creating the momentum needed to turn possibilities into breakthroughs in research 🔬 . More about Dr. Severine Vermeire and her contributions to the field here ⤵️ ibd-leuven.com/medical-staff-…

Bluesky adds 700,000 new members as users flee X after the US election dlvr.it/TG7Jtl

Why the Guardian is no longer posting on X theguardian.com/media/2024/nov…

📌 'La Vanguardia' deja de publicar tuits de forma directa en la red social X, convertida en una red de desinformación desde la llegada de Musk lavanguardia.com/vida/20241114/…

🔬 Basic scientists, submit your translational research to UEGJ and make a difference in patient care. With #UEGJ, you'll have access to a global community of digestive health experts to review and publish your work. bit.ly/3OoWizy #weareUEG #myUEGcommunity

We are thrilled to share an HCA Collection of 40+ peer-reviewed papers in Nature Portfolio shedding light on human development, healthy and disease biology and vital analytical tools. #HCA2024NatureCollection #HumanCellAtlas nature.com/immersive/d428…

Proud of our team's contribution to this amazing effort led by Teichlab nature.com/articles/s4158…

Nuestro grupo IBD lab en las noticias 🔬🧬#ibd #scRNA elpais.com/ciencia/2024-1…

We believe that the most effective way to help individuals at risk of developing Crohn’s disease is to prevent the condition from developing in the first place or to delay disease progression for as long as possible. Our Prevention focus area supports projects aimed at improving

FIBROTARGET aims to change the status quo in #IBD research with novel therapeutics for fibrosis. We spoke with one of FIBROTARGET's researchers Victoria Gudiño from IDIBAPS (Hospital Clínic) about her role and its impact. 🗞️ Read the full interview: loom.ly/tQKNvNI

Raquel Bartolomé-Casado, Azucena Salas and I have joined forces to gather the current scRNA-seq and/or ST studies in #IBD. From validating previous findings to identifying new cell types... these technologies are really revolutionising the field! Check out our review in #gut for more :)

Patients from our unit visited our lb to learn about our research! It was a priviledge for the entire team🙌🏻 thanks🫶🏻